1. Steurer MA, Peyvandi S, Baer RJ, MacKenzie T, Li BC, Norton ME, et al. Epidemiology of live born infants with nonimmune hydrops fetalis-insights from a population-based dataset. J Pediatr. 2017; 187:182–188.e3.
Article
2. Patni B. Developmental assessment scales for Indian infants (DASII). Ind J Pract Pediatr. 2012; 14:409–412.
3. Tsai MH, Chu SM, Lien R, Huan HR, Luo CC. Clinical manifestations in infants with symptomatic meconium peritonitis. Pediatr Neonatol. 2009; 50:59–64.
Article
4. Kamata S, Nose K, Ishikawa S, Usui N, Sawai T, Kitayama Y, et al. Meconium peritonitis in utero. Pediatr Surg Int. 2000; 16:377–379.
5. Dillard JP, Edwards DK, Leopold GR. Meconium peritonitis masquerading as fetal hydrops. J Ultrasound Med. 1987; 6:49–51.
Article
6. Mayock DE, Hickok DE, Guthrie RD. Cystic meconium peritonitis associated with hydrops fetalis. Am J Obstet Gynecol. 1982; 142(6 Pt 1):704–705.
Article
7. Fukushima K, Morokuma S, Fujita Y, Tsukimori K, Satoh S, Ochiai M, et al. Short-term and long-term outcomes of 214 cases of non-immune hydrops fetalis. Early Hum Dev. 2011; 87:571–575.
Article
8. Reynolds E, Douglass B, Bleacher J. Meconium peritonitis. J Perinatol. 2000; 20:193–195.
Article
9. Wang CN, Chang SD, Chao AS, Wang TH, Tseng LH, Chang YL. Meconium peritonitis
in utero---the value of prenatal diagnosis in determining neonatal outcome. Taiwan J Obstet Gynecol. 2008; 47:391–396.
Article